메뉴 건너뛰기




Volumn 49, Issue 1, 2015, Pages 6-13

A Randomized Trial of Loading Vancomycin in the Emergency Department

Author keywords

emergency department; pharmacokinetics; trough; vancomycin

Indexed keywords

ANTIHISTAMINIC AGENT; CREATININE; HYDROMORPHONE; LACTIC ACID; VANCOMYCIN; ANTIINFECTIVE AGENT;

EID: 84919608313     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014556813     Document Type: Article
Times cited : (41)

References (19)
  • 1
    • 62449183879 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    • ,,, et al.. ;:-
    • Rybak M,Lomaestro B,Rotschafer JC, et al.Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.Am J Health Syst Pharm. 2009;66:82-98
    • (2009) Am J Health Syst Pharm , vol.66 , pp. 82-98
    • Rybak, M.1    Lomaestro, B.2    Rotschafer, J.C.3
  • 2
    • 67651083250 scopus 로고    scopus 로고
    • Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Disease Pharmacists
    • ,,, et al.. ;:-
    • Rybak M,Lomaestro B,Rotschafer JC, et al.Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Disease Pharmacists.Clin Infect Dis. 2009;49:325-327
    • (2009) Clin Infect Dis , vol.49 , pp. 325-327
    • Rybak, M.1    Lomaestro, B.2    Rotschafer, J.C.3
  • 3
    • 79953907324 scopus 로고    scopus 로고
    • Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets
    • Kullar R,Davis SL,Levine DP,Rybak MJ.Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.Clin Infect Dis. 2011;52:975-981
    • (2011) Clin Infect Dis , vol.52 , pp. 975-981
    • Kullar, R.1    Davis, S.L.2    Levine, D.P.3    Rybak, M.J.4
  • 4
    • 50949085411 scopus 로고    scopus 로고
    • Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
    • ,,, et al.. ;:-
    • Lodise TP,Graves J,Evans A, et al.Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.Antimicrob Agents Chemother. 2008;52:3315-3320
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3315-3320
    • Lodise, T.P.1    Graves, J.2    Evans, A.3
  • 5
    • 29244442296 scopus 로고    scopus 로고
    • The pharmacokinetic and pharmacodynamic properties of vancomycin
    • Rybak MJ.The pharmacokinetic and pharmacodynamic properties of vancomycin.Clin Infect Dis. 2006;42:S35-S39
    • (2006) Clin Infect Dis , vol.42 , pp. S35-S39
    • Rybak, M.J.1
  • 6
    • 0031952586 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men
    • Craig WA.Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.Clin Infect Dis. 1998;26:1-12
    • (1998) Clin Infect Dis , vol.26 , pp. 1-12
    • Craig, W.A.1
  • 7
    • 7444254040 scopus 로고    scopus 로고
    • Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
    • Moise-Broder PA,Forrest A,Brimingham MC,Schentag JJ.Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.Clin Pharmacokinet. 2004;43:925-942
    • (2004) Clin Pharmacokinet , vol.43 , pp. 925-942
    • Moise-Broder, P.A.1    Forrest, A.2    Brimingham, M.C.3    Schentag, J.J.4
  • 8
    • 84864609103 scopus 로고    scopus 로고
    • Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort
    • Kullar R,Davis SL,Taylor TN,Kaye KS,Rybak MJ.Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.Pharmacotherapy. 2012;32:195-201
    • (2012) Pharmacotherapy , vol.32 , pp. 195-201
    • Kullar, R.1    Davis, S.L.2    Taylor, T.N.3    Kaye, K.S.4    Rybak, M.J.5
  • 9
    • 33645118294 scopus 로고    scopus 로고
    • Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteremia
    • Sakoulas G,Gold HS,Cohen RA,Venkataraman L,Moellering RC,Eliopoulos GM.Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteremia.J Antimicrob Chemother. 2006;57:699-704
    • (2006) J Antimicrob Chemother , vol.57 , pp. 699-704
    • Sakoulas, G.1    Gold, H.S.2    Cohen, R.A.3    Venkataraman, L.4    Moellering, R.C.5    Eliopoulos, G.M.6
  • 12
    • 0033929727 scopus 로고    scopus 로고
    • Multilevel analysis in public health research
    • Diez-Roux AV.Multilevel analysis in public health research.Annu Rev Public Health. 2000;21:171-192
    • (2000) Annu Rev Public Health , vol.21 , pp. 171-192
    • Diez-Roux, A.V.1
  • 13
    • 77649173768 scopus 로고
    • Longitudinal data analysis using generalized linear models
    • Liang KY,Zeger SL.Longitudinal data analysis using generalized linear models.Biometrika. 1986;73:13-22
    • (1986) Biometrika , vol.73 , pp. 13-22
    • Liang, K.Y.1    Zeger, S.L.2
  • 16
    • 0025834370 scopus 로고
    • Necessity of a loading dose when using vancomycin in critical-ill patients
    • Soto J,Sacristan JA,Alsar MJ.Necessity of a loading dose when using vancomycin in critical-ill patients.J Antimicrob Chemother. 1991;27:875
    • (1991) J Antimicrob Chemother , vol.27 , pp. 875
    • Soto, J.1    Sacristan, J.A.2    Alsar, M.J.3
  • 17
    • 0035131694 scopus 로고    scopus 로고
    • Necessity of a loading dose when using vancomycin in critically ill patients
    • Wang JT,Fang CT,Chen YC,Chang SC.Necessity of a loading dose when using vancomycin in critically ill patients.J Antimicrob Chemother. 2001;47:246
    • (2001) J Antimicrob Chemother , vol.47 , pp. 246
    • Wang, J.T.1    Fang, C.T.2    Chen, Y.C.3    Chang, S.C.4
  • 18
    • 67651113645 scopus 로고    scopus 로고
    • Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients
    • Lodise TP,Patel N,Lomaestro BM,Rodvold KA,Drusano GL.Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.Clin Infect Dis. 2009;49:507-514
    • (2009) Clin Infect Dis , vol.49 , pp. 507-514
    • Lodise, T.P.1    Patel, N.2    Lomaestro, B.M.3    Rodvold, K.A.4    Drusano, G.L.5
  • 19
    • 84856176691 scopus 로고    scopus 로고
    • Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP database
    • ,,, et al.. ;:-
    • Cano EL,Haque NZ,Welch VL, et al.Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP database.Clin Ther. 2012;34:149-157
    • (2012) Clin Ther , vol.34 , pp. 149-157
    • Cano, E.L.1    Haque, N.Z.2    Welch, V.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.